|
Pfizer Inc and Subsidiary Companies
|
|
|
|
|
|
|
|
|
|
(millions of dollars) |
|
United States(6) |
Europe |
Asia |
Canada/ Latin America |
Africa/ Middle East |
Corporate/ Other |
Adjustments/ Eliminations |
Consolidated |
|
Total revenues |
1997 |
|
$6,867 |
|
$2,853 |
|
$1,675 |
|
$849 |
|
260 |
|
$ |
|
$ |
|
$12,504(1) |
|
1996 |
|
5,941 |
|
2,773 |
|
1,598 |
|
750 |
|
244 |
|
$ |
|
$ |
|
$11,306 |
|
1995 |
|
5,113 |
|
2,444 |
|
1,538 |
|
696 |
|
230 |
|
$ |
|
$ |
|
$10,021 |
|
Intercompany sales |
1997 |
|
196 |
|
881 |
|
75 |
|
64 |
|
11 |
|
|
|
(1,227) |
|
|
|
1996 |
|
197 |
|
813 |
|
84 |
|
35 |
|
9 |
|
|
|
(1,138) |
|
|
|
1995 |
|
175 |
|
692 |
|
75 |
|
29 |
|
10 |
|
|
|
(981) |
|
|
|
Total |
1997 |
|
7,063 |
|
3,734 |
|
1,750 |
|
913 |
|
271 |
|
|
|
(1,227) |
|
12,504(1) |
|
1996 |
|
6,138 |
|
3,586 |
|
1,682 |
|
785 |
|
253 |
|
|
|
(1,138) |
|
11,306 |
|
1995 |
|
5,288 |
|
3,136 |
|
1,613 |
|
725 |
|
240 |
|
|
|
(981) |
|
10,021 |
|
Geographic profit/(loss) |
1997 |
|
2,251 |
|
1,012 |
|
233 |
|
42 |
|
7 |
|
(372)(2) |
|
(85) |
|
3,088(3) |
|
1996 |
|
2,018 |
|
1,013 |
|
250 |
|
29 |
|
(5) |
|
(423)(2) |
|
(78) |
|
2,804(3) |
|
1995 |
|
1,628 |
|
778 |
|
261 |
|
49 |
|
12 |
|
(382)(2) |
|
(47) |
|
2,299(3) |
|
Identifiable assets(7) |
1997 |
|
4,665 |
|
4,317 |
|
1,202 |
|
570 |
|
151 |
|
5,599 |
|
(1,168) |
|
15,336 |
|
1996 |
|
4,424 |
|
4,072 |
|
1,278 |
|
606 |
|
174 |
|
5,265 |
|
(1,152) |
|
14,667 |
|
1995 |
|
3,199 |
|
3,647 |
|
1,243 |
|
612 |
|
193 |
|
4,796(5) |
|
(961) |
|
12,729 |
|
(1)Includes alliance revenue of $316 million. |
(2)Includes interest income/(expense) and corporate expenses. Also includes other income/(expense) of the financial subsidiaries (see note 3, Financial Subsidiaries). |
(3)Consolidated total equals income from continuing operations before provision for taxes on income and minority interests. |
(4)Certain production facilities are shared by various segments. Property, plant and equipment, as well as capital additions and depreciation, are allocated based on physical production. Corporate assets are primarily cash, short-term investments and long-term marketable securities. |
(5)Includes amounts for the food science business which was sold in 1996. |
(6)Includes operations in Puerto Rico. |
(7)Products are transferred between geographic areas for additional processing and ultimate sale, on a basis intended to recognize economic and competitive circumstances in the market of end use. These figures reflect the physical location of assets even though these assets provide goods and services to other areas. |
|